Authors:
JASSEM J
ZATLOUKAL P
KANITZ E
MAGYAR P
KRZAKOWSKI M
PAWLICKI M
PETRUZELKA L
CHOVAN L
PESEK M
KREJCY K
Citation: J. Jassem et al., GEMCITABINE IN LOCALLY ADVANCED AND METASTATIC NONSMALL CELL LUNG-CANCER (NSCLC) - THE CENTRAL-EUROPEAN PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 433-433
Authors:
MANEGOLD C
DRINGS P
PAWINSKI A
LENTZ MA
VANGLABBEKE M
VANZANDWIJK N
BACHMANN P
SCHNAARS Y
SKACEL Z
ZATLOUKAL P
DOLENSKY J
JACKEVICIUS A
PETRUZELKA L
GIACCONE G
Citation: C. Manegold et al., ORAL IFOSFAMIDE MESNA VERSUS INTRAVENOUS IFOSFAMIDE/MESNA IN NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II TRIAL OF THE EORTC LUNG-CANCER COOPERATIVE GROUP/, Annals of oncology, 7(6), 1996, pp. 637-639
Citation: M. Zemanova et al., SYMPTOMATIC BENEFIT OF PALLIATIVE RADIOTHERAPY FOR PATIENT WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, European journal of cancer, 31A, 1995, pp. 173-173